Blog Articles, tagged with: Treatment

Survey: Disease Modifying Therapies

Thumbnail

Suvey Closed on Tuesday, 2nd October 2017 What is important to people with MS regarding treatment options MS Ireland is conducting a short, anonymous survey about disease modifying therapies (DMTs). This survey is open to anyone with a diagnosis of MS or Clinically Isolated Syndrome. You do not...

Published by MS Ireland on Tuesday September 12 2017 06:49 PM

View Article

Stem Cells

Thumbnail

MS Ireland's Statement ref: Autologous Haematopoietic Stem Cell Transplantation (AHSCT)  'Multiple Sclerosis Ireland welcomes progress in stem cell treatment for people with MS, as news of success in the UK with Autologous Haematopoietic Stem Cell Transplantation (AHSCT) (sometimes referre...

Published by MS Ireland on Tuesday January 19 2016 11:30 AM

View Article

UPDATE: Fampyra

Thumbnail

Fampyra to be reimbursed for people with MS on a responder basis Multiple Sclerosis Ireland welcomes the news that that the HSE will reimburse Fampyra or Fampridine in cases where people with MS ‘satisfy a responder protocol’ and have been prescribed the drug by a healthcare professi...

Published by MS Ireland on Thursday October 01 2015 01:58 PM

View Article

'Voice of the Patient' Survey

Thumbnail

Have Your Say There are several surveys on MS, none of them are entirely focussed on the needs and situation of people with MS in terms of employment, treatment, support, adapted living environment and care. The Pan-European EMSP Voice of the Patient Survey will ask your opinion about your life ...

Published by EMSP on Wednesday August 19 2015 03:02 PM

View Article

New Treatments For Relapsing-Remitting MS

Thumbnail

Tecfidera and Plegridy have been made available in Ireland for people with RRMS MS Ireland welcomes the news that two new treatments for relapsing-remitting MS (RRMS) have been made available in Ireland. Tecfidera, an oral treatment and Plegridy, an injectable treatment, are both therapies for R...

Published by MS Ireland on Tuesday February 17 2015 09:37 AM

View Article

Fampyra® Available in Ireland

Thumbnail

Biogen Idec announce availability of Fampyra® to treat walking impairment in adults with MS Biogen Idec announced that FAMPYRA® (prolonged-release fampridine tablets) has been made available in Ireland for the symptomatic treatment of walking impairment in adults with Multiple Sclerosis ...

Published by Biogen Idec on Friday January 16 2015 09:56 AM

View Article


Latest News

More news

What's hot

Small_camera-photographer-yellow-photography

Enter our 2020 Calendar Competition!

Calling all budding photographers! Enter our competition to see YOUR photo in our new calendar!

Find out more

Events Calendar

» Our next Event

19 June 2019: Physiotherapist led Exercise classes for people with MS, starts 9th January (ongoing)

View all events

eNEWS SIGNUP

If you'd like to receive e-news updates from The Society please enter your email address below. If you want to know more about how we manage personal data then please see our privacy policy.

My local MSI

Map of MS Ireland's service areas South Mid West West Midlands South East North East North West North Dublin City and Fingal South West Dublin and Kildare South East Dublin and Wicklow